| Profile | GDS4177 / 202032_s_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 1720.88 | 97 |
| GSM603099 | KU-812 non-treated | 1168.94 | 96 |
| GSM603098 | KCL-22 Imatinib-treated | 606.99 | 91 |
| GSM603097 | KCL-22 non-treated | 398.9 | 87 |
| GSM603102 | JURL-MK1 Imatinib-treated | 945.36 | 95 |
| GSM603101 | JURL-MK1 non-treated | 394.06 | 87 |